MACKENZIE ALTHOUSE: Open Payments
NPI 1679032072 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 21 payments from 12 companies in 2025. Trend: 2023 $801 · 2024 $691 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $65 |
| Tris Pharma Inc | 4 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Corium, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Boston Scientific Corporation | 1 | $26 |
| Almatica Pharma LLC | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
Products named: INGREZZA, Dyanavel XR, Jornay PM, REXULTI, INVEGA SUSTENNA, Azstarys, AMS 700, LOREEV XR.
Industry payments across FL — which companies pay providers there.
